Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
CRA-2059 is a highly specific and selective tryptase inhibitor
18-pentaen-6-yl (2S)-2-[N-methyl-4-(methyldisulfanyl)pentanamido]propanoate
Senexin B shows synergy with fulvestrant in MCF7
01) and REMS (F(3
2-fold increased agonism and a 22-fold decreased cdk2 kinase activity versus the standard
O-1918 Size:Contact [email protected] for quotation CRA-2059 is a highly specificAbnormal cannabidiol is a synthetic regioisomer of cannabidiol that fails to elicit either central cannabinoid (CB1) or peripheral cannabinoid (CB2) responsiveness and is without psychotropic activity. It induces endothelium dependent vasodilation via a CB1 CB2 nitric oxide independent mechanism. O 1918 is a cannabidiol analog that acts as a selective antagonist of abnormal cannabidiol at the non CB1 CB2 endothelial receptor. It does not bind to CB1